[{"id":"d1048c94-842b-49ba-bca0-620729b39374","acronym":"","url":"https://clinicaltrials.gov/study/NCT02166242","created_at":"2021-01-18T10:05:16.295Z","updated_at":"2024-07-02T16:36:15.322Z","phase":"Phase 1c","brief_title":"Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers","source_id_and_acronym":"NCT02166242","lead_sponsor":"Hunan Province Tumor Hospital","biomarkers":" EGFR • ALK","pipe":"","alterations":" ","tags":["EGFR • ALK"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 06/01/2014","start_date":" 06/01/2014","primary_txt":" Primary completion: 12/01/2020","primary_completion_date":" 12/01/2020","study_txt":" Completion: 12/01/2021","study_completion_date":" 12/01/2021","last_update_posted":"2022-03-16"}]